AMDA 2010 Research Grant Opportunity

Posted on: July 31, 2010 - Filed under

The AMDA is excited to announce a research grant opportunity for applicants who are involved in Pompe Disease research. This grant opportunity was made possible by a private fundraiser aimed at promoting research into Pompe Disease.

If you are interested in this opportunity, please download the following Letter to Applicants and Grant Application.

The application deadline is: Friday, September 3, 2010.

Thank you,

Tiffany House
AMDA President

Download: Letter to Applicants
Download: Grant Application

View complete article

---

Other News

• Pompe Patient Meeting Hosted by Columbia University
  Posted on June 14, 2010 - Filed under
• Pompe Program Update—FDA Approves Lumizyme
  Posted on May 27, 2010 - Filed under
• The FDA Approves Lumizyme for Late-Onset Pompe Disease
  Posted on May 26, 2010 - Filed under
• Pompe Disease: The Real Story
  Posted on January 21, 2010 - Filed under
• AMDA Press Release Regarding Extraordinary Measures
  Posted on January 20, 2010 - Filed under
• ATAP Inclusion/Exclusion and List of Study Sites
  Posted on December 07, 2009 - Filed under
• December 2009 Pompe Program Update
  Posted on December 04, 2009 - Filed under Pompe Program Update
• Influenza Vaccinations and Pompe Disease
  Posted on November 27, 2009 - Filed under
• Genzyme invites the Gaucher, Fabry, Pompe and MPS I communities to a Town Hall Meeting
  Posted on November 21, 2009 - Filed under
• November 2009 Pompe Program Update from Genzyme
  Posted on November 17, 2009 - Filed under Pompe Program Update
• November 2009 Pompe Program Update from Genzyme
  Posted on November 17, 2009 - Filed under Pompe Program Update
• Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease
  Posted on October 01, 2009 - Filed under
• Genzyme’s Second Quarter Earnings Statement
  Posted on July 23, 2009 - Filed under
• Genzyme Submits All Information Requested by FDA for Lumizyme
  Posted on May 22, 2009 - Filed under
• IPA Statement: The End of Myozyme Supply Restrictions
  Posted on May 08, 2009 - Filed under
• Pompe Program Update from Genzyme
  Posted on March 02, 2009 - Filed under Pompe Program Update
• Genzyme Receives Complete Response Letter from FDA   on Lumizyme Application
  Posted on March 02, 2009 - Filed under
• Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe
  Posted on February 27, 2009 - Filed under
• European Authorities Approve Larger-Scale Production of Genzyme’s Myozyme
  Posted on February 26, 2009 - Filed under

View complete archive